Kathryn Amirikia, MD
General Surgery · Folsom
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 33 years
- Wayne State University School of Medicine, 1993
Offices
1 location
Hospitals listed: Methodist Hospital of Sacramento. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Amirikia’s office at (916) 947-0967 to ask if they take your plan before you enroll.
California Medical Board record
Licence G86919 · Current
Licensed to practise in California · since 2003 · expires 2027-05-31 · Wayne State University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Methodist Hospital of SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 63% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.059, Oct 2024 – Sep 2025
See every measure and the patient survey for Methodist Hospital of Sacramento
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 1 better, 3 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.059 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.04) · 414 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.43 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.4 · 67 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 222 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.3 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 7.4 · 152 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,465 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,886 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.49) · 2,999 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.01 (0.56 to 5.47) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.22 (0.53 to 3.91) · 322 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.95 (0 to 18.9) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.04 (0.78 to 9.3) · 77 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.26 (0 to 1.13) · 2,441 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 46 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 1.388 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 471 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.4 · 248 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 37.7 · 242 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.2 · 375 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 39 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 190 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.5 to 17) · 198 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.6) · 77 cases | No different | Jan 2024 – Dec 2024 |
What patients said (553 patients answered, 12% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 63% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$24,360
Medicare paid this office $24,360 for 72 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 32 | $5,104 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,095 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,815 | $96 |
| New patient visit (45+ min) | 13 | $1,669 | $128 |
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Mastectomy | 24 | More than 82% of doctors who do this |
| Removal of tissue | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of gallbladder using an endoscope | 21 | – | 15 | 11 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
72 Original Medicare patients in 2024. Average age 71 · Women 76% · Also on Medicaid 83% · Health risk score 1.82. Above the middle of the specialty; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 75% · Cancer 57% · Diabetes 44% · Chronic kidney disease 33% · Coronary heart disease 26% · Depression 25% · Heart failure 24% · COPD 21% · Dementia 21%.
The office billed $60,500, Medicare allowed $32,401 and paid $24,360; for 149 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 72 | 149 | 71 | 1.82 | $60,500 | $24,360 |
| 2023 | 71 | 189 | 71 | 1.93 | $71,300 | $27,828 |
| 2022 | 76 | 170 | 67 | 1.52 | $89,750 | $31,228 |
| 2021 | 87 | 157 | 69 | 1.48 | $96,550 | $29,937 |
| 2020 | 98 | 176 | 68 | 1.72 | $114,100 | $32,608 |
| 2019 | 139 | 262 | 69 | 1.63 | $136,350 | $46,094 |
| 2018 | 159 | 317 | 67 | 2.06 | $177,150 | $46,374 |
| 2017 | 121 | 210 | 66 | 1.86 | $188,800 | $33,424 |
| 2016 | 162 | 336 | 69 | 1.39 | $348,440 | $65,260 |
| 2015 | 180 | 419 | 70 | 1.33 | $407,773 | $90,374 |
| 2014 | 142 | 263 | 69 | 1.44 | $164,619 | $49,184 |
| 2013 | 163 | 352 | 67 | 1.65 | $250,404 | $74,496 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 31 | $4,632 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $3,410 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,850 | $106 |
| New patient visit (45+ min) | 15 | $1,516 | $101 |
2022: 4 services
| Removal of gallbladder using an endoscope | 11 | $5,644 | $513 |
| Return visit (30+ min) | 29 | $4,727 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,059 | $109 |
| New patient visit (45+ min) | 16 | $1,919 | $120 |
2021: 4 services
| Return visit (30+ min) | 26 | $4,963 | $103 |
| Removal of gallbladder using an endoscope | 15 | $3,877 | $258 |
| New patient visit (45+ min) | 16 | $2,107 | $132 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,561 | $104 |
2020: 4 services
| Return visit (30+ min) | 28 | $3,417 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,814 | $113 |
| New patient visit (45+ min) | 12 | $1,565 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,213 | $87 |
2019: 5 services
| Return visit (30+ min) | 36 | $5,293 | $81 |
| Removal of gallbladder using an endoscope | 21 | $5,249 | $250 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $3,781 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,546 | $59 |
| New patient visit (45+ min) | 16 | $2,030 | $127 |
2018: 9 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 46 | $5,037 | $107 |
| Removal of gallbladder using an endoscope | 15 | $4,386 | $292 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $3,911 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $2,471 | $82 |
| Return visit (30+ min) | 21 | $2,281 | $79 |
| Partial removal of stomach for weight loss using an endoscope | 13 | $1,788 | $138 |
| New patient visit (45+ min) | 13 | $1,587 | $122 |
| New patient visit (30+ min) | 16 | $1,295 | $81 |
| Short return visit (20+ min) | 11 | $1,056 | $59 |
2017: 5 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 47 | $5,104 | $106 |
| Partial removal of stomach for weight loss using an endoscope | 15 | $2,033 | $136 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,576 | $56 |
| Return visit (30+ min) | 13 | $1,280 | $67 |
| New patient visit (45+ min) | 11 | $902 | $82 |
2016: 12 services
| Partial removal of breast | 16 | $9,547 | $502 |
| Biopsy or removal of deep lymph nodes of underarm | 17 | $3,349 | $197 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,822 | $109 |
| New patient visit (45+ min) | 16 | $2,111 | $132 |
| Return visit (30+ min) | 18 | $2,072 | $80 |
| New patient visit (60+ min) | 16 | $2,032 | $127 |
| Partial removal of stomach for weight loss using an endoscope | 15 | $1,936 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,899 | $83 |
| Imaging of lymph nodes during surgery | 12 | $1,325 | $110 |
| Return visit (30+ min) | 16 | $1,210 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,203 | $57 |
| Short return visit (20+ min) | 18 | $829 | $38 |
2015: 10 services
| Partial removal of breast | 33 | $17,679 | $520 |
| Biopsy or removal of deep lymph nodes of underarm | 35 | $6,840 | $190 |
| Removal of gallbladder using an endoscope | 14 | $4,862 | $347 |
| New patient visit (60+ min) | 32 | $4,333 | $135 |
| Imaging of lymph nodes during surgery | 26 | $2,843 | $109 |
| Return visit (30+ min) | 21 | $2,517 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,244 | $160 |
| New patient visit (45+ min) | 18 | $2,224 | $124 |
| New patient visit (45+ min) | 12 | $1,147 | $96 |
| Return visit (30+ min) | 16 | $1,073 | $63 |
2014: 5 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,538 | $163 |
| Return visit (30+ min) | 43 | $5,330 | $81 |
| Removal of gallbladder using an endoscope | 11 | $4,879 | $444 |
| New patient visit (45+ min) | 15 | $2,015 | $134 |
| New patient visit (60+ min) | 12 | $2,007 | $167 |
2013: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $9,051 | $159 |
| Removal of gallbladder using an endoscope | 17 | $7,647 | $450 |
| Return visit (30+ min) | 31 | $4,344 | $82 |
| New patient visit (45+ min) | 27 | $3,468 | $128 |
| New patient visit (60+ min) | 15 | $2,367 | $158 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,562 | $31 |
| New patient visit (30+ min) | 13 | $1,147 | $88 |
Medicaid work
$1,860 in 2024
Medicaid paid $1,860 for 282 billed services this clinician did in 2024, up to 39 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 282 | $1,860 |
| 2024 | 282 | 1 | 39 | $1,860 |
| 2023 | 495 | 5 | 38 | $1,807 |
| 2022 | 639 | 9 | 47 | $1,573 |
| 2021 | 430 | 3 | 38 | $1,009 |
| 2020 | 307 | 3 | 33 | $1,317 |
| 2019 | 261 | 6 | 19 | $9,625 |
| 2018 | 73 | 5 | 13 | $8,572 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 383 | $1,475 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 45 | $133 |
| Unclassified drugs | 40 | $132 |
| Injection, ondansetron hydrochloride, per 1 mg | 14 | $56 |
| Fentanyl citrate injection | 13 | $12 |
2022
| Return visit (30+ min) | 419 | $1,230 |
| Unclassified drugs | 66 | $268 |
| Fentanyl citrate injection | 25 | $27 |
| Injection, propofol, 10 mg | 14 | $13 |
| Injection, ondansetron hydrochloride, per 1 mg | 15 | $13 |
| Injection, dexamethasone sodium phosphate, 1 mg | 14 | $12 |
| Ringers lactate infusion, up to 1000 cc | 13 | $9 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 58 | $0 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 15 | $0 |
2021
| Return visit (30+ min) | 363 | $536 |
| Laparoscopy, surgical, gastric restrictive procedure; longitudinal gastrectomy (ie, sleeve gastrectomy) | 12 | $472 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 55 | $0 |
2020
| Laparoscopy, surgical, gastric restrictive procedure; longitudinal gastrectomy (ie, sleeve gastrectomy) | 13 | $923 |
| Return visit (30+ min) | 254 | $394 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 40 | $0 |
2019
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 18 | $8,493 |
| Service | 12 | $556 |
| Return visit (30+ min) | 180 | $278 |
| Injection, propofol, 10 mg | 25 | $176 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 14 | $106 |
| Fentanyl citrate injection | 12 | $16 |
2018
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 18 | $7,811 |
| Service | 15 | $708 |
| Cefazolin sodium injection | 14 | $35 |
| Fentanyl citrate injection | 14 | $18 |
| Return visit (30+ min) | 12 | $0 |
Drugs they prescribed that Part D paid
$215
Pharmacies billed $215 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 63% of their Part D prescriptions (25 of 40) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
40 generic and 0 brand-name prescriptions · $215 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 21 | $69 | $3 |
Year by year
| 2024 | 40 | 27 | 63% (25) | 0% | $215 |
| 2023 | 35 | 21 | 66% (23) | None | $205 |
| 2022 | 57 | 42 | 67% (38) | None | $498 |
| 2021 | 30 | 19 | 47% (14) | None | $175 |
| 2020 | 26 | 20 | 77% (20) | 0% | $160 |
| 2019 | 63 | 34 | 38% (24) | 0% | $684 |
| 2018 | 59 | 31 | 53% (31) | None | $1,706 |
| 2017 | 50 | 30 | 52% (26) | None | $1,775 |
| 2016 | 51 | 32 | 59% (30) | 0% | $576 |
| 2015 | 47 | 38 | 62% (29) | None | $641 |
| 2014 | 81 | 46 | 63% (51) | None | $2,138 |
| 2013 | 141 | 69 | 75% (105) | 0% | $1,833 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Hydrocodone-Acetaminophen | 17 | $77 | $5 |
2022: 1 drug
| Hydrocodone-Acetaminophen | 37 | $168 | $5 |
2021: 1 drug
| Hydrocodone-Acetaminophen | 14 | $66 | $5 |
2020: 1 drug
| Hydrocodone-Acetaminophen | 18 | $107 | $6 |
2019: 2 drugs
| Cephalexin | 20 | $190 | $10 |
| Hydrocodone-Acetaminophen | 22 | $157 | $7 |
2018: 1 drug
| Hydrocodone-Acetaminophen | 31 | $384 | $12 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 22 | $216 | $10 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 26 | $352 | $14 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 26 | $292 | $11 |
2014: 2 drugs
| Hydrocodone-Acetaminophen | 49 | $397 | $8 |
| Cephalexin | 13 | $126 | $10 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 95 | $907 | $10 |
Money from drug and device companies
$1,367 in 2025
| 2025 | 3 | 9 | None | $1,367 |
| 2024 | 3 | 14 | None | $3,968 |
| 2023 | 1 | 1 | None | $21 |
| 2022 | 4 | 5 | None | $106 |
| 2021 | 2 | 2 | None | $62 |
| 2020 | 1 | 1 | None | $16 |
| 2019 | 1 | 1 | None | $134 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Intuitive Surgical | Da Vinci Surgical System | $1,317 | 7 payments
|
| Vertex Pharmaceuticals | None | $29 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Enhertu | $22 | 1 payment
|
See all 9 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-15 | Enhertu | $22 |
| Vertex Pharmaceuticals | Meals · 2025-04-22 | None | $29 |
| Intuitive Surgical | Meals · 2025-04-11 | Da Vinci Surgical System | $378 |
| Intuitive Surgical | Travel · 2025-02-24 | Da Vinci Surgical System | $737 |
| Intuitive Surgical | Travel · 2025-02-24 | Da Vinci Surgical System | $37 |
| Intuitive Surgical | Travel · 2025-02-10 | Da Vinci Surgical System | $19 |
| Intuitive Surgical | Meals · 2025-01-07 | Da Vinci Surgical System | $5 |
| Intuitive Surgical | Travel · 2025-01-07 | Da Vinci Surgical System | $80 |
| Intuitive Surgical | Meals · 2025-01-07 | Da Vinci Surgical System | $60 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,968
| Intuitive Surgical | Davinci Xi | $3,924 | 12 payments
|
| Novartis Pharmaceuticals | None | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Enhertu | $22 | 1 payment
|
2023: $21
| AstraZeneca Pharmaceuticals LP | Enhertu | $21 | 1 payment
|
2022: $106
| GE HealthCare | None | $41 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Enhertu | $35 | 2 payments
|
| Allergan | Natrelle Saline-Filled Breast Implants | $18 | 1 payment
|
| Innocoll Pharmaceuticals | Xaracoll | $12 | 1 payment
|
2021: $62
| Innocoll | Xaracoll | $35 | 1 payment
|
| Medtronic | Signia | $27 | 1 payment
|
2020: $16
| Olympus America | Thunderbeat | $16 | 1 payment
|
2019: $134
| Hologic | Biozorb | $134 | 1 payment
|
Professional record
- NPI
- 1992813406
- Licence
- CA G86919, MI 4301061506California G86919: Current · expires 2027-05-31
- Trained
- Wayne State University School of Medicine, 1993 · 33 years ago
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Medicaid ID
- MI 2612952
- Taxonomy
- Surgery (208600000X); Surgical oncology (2086X0206X)
- Mailing address
- 1737 Creekside Dr, Folsom, CA, 95630
- NPI first listed
- 2006-08-25
- NPI last updated
- 2021-04-08
- NPI record certified
- 2021-04-08
This is when the NPI record was last certified, not a medical board exam.